Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer

Lung Cancer

Volumn 37, Issue 1, 2002, Pages 79-85

  Maranzano, Ernesto ^a   Crinò, Lucio ^b   Piro, Fabrizio ^c   Meacci, Luisa ^a   Bracarda, Sergio ^a   De Angelis, Verena ^d   Darwish, Samir ^a   Minotti, Vincenzo ^a   Panizza, Bianca Moira ^a   De Marinis, Filippo ^e   Latini, Paolo ^a,f   Tonato, Maurizio ^a  

^a Medical Oncology Division   (Italy)

^b BELLARIA HOSPITAL   (Italy)

^c Mariano Santo Hospital   (Italy)

^d ASL 2   (Italy)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Concomitant chemo radiotherapy; Induction chemotherapy; Limited disease; Small cell lung cancer; Thoracic irradiation

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; ANTINEOPLASTIC AGENT; CEV PROTOCOL;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; IRRADIATION; LUNG SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; THORAX; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; LUNG TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESOPHAGITIS; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; NEUTROPENIA; SURVIVAL; TREATMENT OUTCOME; VINCRISTINE; HUMANS; MIDDLE AGED;

EID: 0035985192     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00028-4     Document Type: Article

References (35)

1. Twenty years of phase II trials for patients with extensive-stage small-cell lung cancer: Perceptible progress
2. A meta-analysis of thoracic radiotherapy for small-cell lung cancer
3. Combined chemotherapy and radiotherapy in the treatment of limited small cell lung carcinoma
4. VP16 and cisplatin as first line therapy for small-cell lung cancer
5. Cisplatin plus etoposide consolidation following cyclophospamide, doxorubicin and vincristine in limited small-cell lung cancer
6. High-dose etoposide (VP16) in small-cell lung broncogenic carcinoma
7. High-dose intensification therapy with autologous bone marrow support for limited small-cell broncogenic carcinoma
8. A randomized trial comparing 'standard' three-weekly chemotherapy (CT) in patients (PTS) with small-cell lung cancer (SCLC)
9. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Group
10. A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer
11. Alternate strategies for limited stage small cell lung cancer
12. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer
13. Phase III study of concurrent vs. sequential thoracic radiotherapy (TRT) in combination with cisplatin (C) and etoposide (E) for limited stage (LS) small-cell lung cancer (SCLC): Preliminary reports of the Japan Clinical Oncology Group (JCOG)
14. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
15. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma
16. Management of small-cell cancer of the lung
17. Randomized trial of altering versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group study
18. Concurrent chemotherapy/radiotherapy for limited small-cell carcinoma of the lung: A Southwest Oncology Group Study
19. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: A randomized trial of Southeastern Cancer Study Group
20. Moderate dose-escalation of combination with chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: Prolonged intrathoracic tumor control and high central nervous system relapse rate
21. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: Results of a British Medical Research Council Multicenter Randomized Trial: Medical Research Council Lung Cancer Working Party
22. Chest radiotherapy in limited-stage small cell lung cancer: Facts, questions, prospects
23. Importance of timing for thoracic irradiation in the combined modality treatment of limited-small-cell lung cancer
24. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited-small cell lung cancer: A randomized study
25. Thoracic radiation therapy added to chemotherapy for small cell lung cancer: An update of Cancer and Leukemia Group B study 8083
26. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited stage small-cell lung cancer
27. A randomized clinical trial comparing concurrent and alternated thoracic irradiation for patients with limited small cell lung carcinoma
28. Alterning radiotherapy and chemotherapy schedules in limited small cell lung cancer: Analysis of local chest recurrences
29. The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of Canadian multicenter randomized trial
30. Little to learn from phase II trials in small-cell lung cancer
31. The value of adjunctive radiotherapy when chemotherapy is the major curative method
32. The evolving role of radiation therapy in the treatment of locally advanced lung cancer
33. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small-cell lung cancer: Results of a multicentric randomised trial
34. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
35. Practice guideline on prophylactic cranial irradiation in small-cell lung cancer